22100 Bothell-Everett Highway
Bothell, WA 98021-8431
USA
Telephone: +1 425-487-7000 or 800-426-2670
Fax: +1 425-485-6080
www.philips.com/ultrasound
This Medical Device meets the provisions of the transposition of the Medical
Device Directive 2007/47/EC within the country of origin of the Notified Body
concerned with the device.
European Union Representative
Philips Medical Systems Nederland B.V.
Quality & Regulatory Affairs
Veenpluis 4-6
5684PC Best
The Netherlands
CAUTION
United States federal law restricts this device to sale by or on the order of a
physician.
This document and the information contained in it is proprietary and confidential information of Philips Medical Systems
("Philips") and may not be reproduced, copied in whole or in part, adapted, modified, disclosed to others, or disseminated
without the prior written permission of the Philips Legal Department. This document is intended to be used by customers
and is licensed to them as part of their Philips equipment purchase. Use of this document by unauthorized persons is
strictly prohibited.
Philips provides this document without warranty of any kind, implied or expressed, including, but not limited to, the
implied warranties of merchantability and fitness for a particular purpose.
Philips has taken care to ensure the accuracy of this document. However, Philips assumes no liability for errors or
omissions and reserves the right to make changes without further notice to any products herein to improve reliability,
function, or design. Philips may make improvements or changes in the products or programs described in this document
at any time.
This product may contain remanufactured parts equivalent to new in performance, or parts that have had incidental use.
Philips Ultrasound products may be manufactured under or operate in accordance with one or more of the following
United States patents and corresponding patents in other countries: U.S. Patent Numbers 5,315,999; 5,381,795; 5,402,793;
5,479,930; 5,482,045; 5,482,047; 5,555,887; 5,603,323; 5,634,465; 5,706,819; 5,715,823; 5,718,229; 5,720,291; 5,735,281;
5,833,613; 5,851,186; 5,879,303; 5,908,389; 5,951,478; 5,961,462; 6,043,590; 6,050,942; 6,126,599; 6,210,328; 6,224,552;
6,231,510; 6,251,074; 6,283,919; 6,299,579; 6,306,089; 6,390,981; 6,416,477; 6,516,215; 6,544,177; 6,629,927; 6,648,825;
6,663,569; 6,676,606; D369,307; Re36,564. Other patent applications are pending in various countries.
2
iU22 User Manual
4535 614 45861
"Color Power Angio," "HDI," "QLAB," "SonoCT," "SONOS," "xMATRIX," and "XRES" are trademarks of Koninklijke
Philips Electronics N.V.
Non-Philips product names may be trademarks of their respective owners.
iU22 User Manual
4535 614 45861
3
4
iU22 User Manual
4535 614 45861
Contents
1Read This First..........................................................................................17
This section contains important information about the user information for
your product and about customer service.
Intended Audience
Before you use your user information, you need to be familiar with ultrasound
techniques. Sonography training and clinical procedures are not included here.
This document is intended for sonographers, physicians, and biomedical
engineers who operate and maintain your Philips product.
Warnings
Before using the system, read these warnings and the "Safety" section.
WARNINGS
•Do not remove system covers; hazardous voltages are present inside the
system. To avoid electrical shock, use only supplied power cords and
connect only to properly grounded wall (wall/mains) outlets.
•Do not operate the system in the presence of flammable anesthetics.
Explosion can result.
•Medical equipment needs to be installed and put into service according
to the special electromagnetic compatibility (EMC) guidelines provided
in the "Safety" section.
•The use of portable and mobile radio-frequency (RF) communications
equipment can affect the operation of medical equipment.
iU22 User Manual
4535 614 45861
17
Read This First
1
Warning Symbols
The system may use the following warning symbols. For additional symbols used
on the system, see the "Safety" section.
Identifies a safety note.
May also indicate that there is an impending loss of data that must be
acknowledged.
Warning: Indicates that there is a possibility of a system malfunction
that might prevent the use of the ultrasound system.
Dangerous voltages: Appears adjacent to high-voltage terminals,
indicating the presence of voltages greater than 1,000 Vac (600 Vac in
the United States).
DescriptionSymbol
18
Identifies ESD (electrostatic-discharge) sensitivity of a connector that
is not tested as specified in IEC 60601-1-2. Do not touch exposed
connector pins. Touching exposed pins can cause electrostatic
discharge, which can damage the product.
Indicates that the user should see the instructions for use for safety
information.
iU22 User Manual
4535 614 45861
User Information Components
The user information provided with your product includes the following
components:
•Compact Disc (CD): Includes all of the user information, except the
Operating Notes. The instructions for using the CD are included with the
CD.
•Operating Notes: Contains information that clarifies certain product
responses that might be misunderstood or cause user difficulty.
•User Manual: Provided with the product and included on the CD. The
User Manual introduces you to features and concepts, helps you set up your
system, and includes important safety information. This manual also includes
procedures for basic operation. For detailed operating instructions, see the
Help.
•PercuNav User Manual : Introduces you to PercuNav features and
concepts, helps you set up your system, includes important safety
information, and provides instructions for use specific to the PercuNav
system when integrated with the ultrasound system. For information about
using the ultrasound system, see the user information for your ultrasound
system.
•Help: Available on the system in some languages and included on the CD,
the Help contains comprehensive instructions for using the system. The
Help also provides reference information and descriptions of all controls
and display elements. To display the Help, press Help on the system
keyboard.
•Voice Control Quick Guide: Provided with the system and included on
the CD, the Voice Control Quick Guide contains procedures for using the
voice control option and lists all commands used for voice control and voice
annotation.
Read This First
1
iU22 User Manual
4535 614 45861
19
Read This First
1
•PercuNav Quick Reference Guide: Provides the most basic, procedural
steps required to operate the PercuNav system.
•Acoustic Output Tables: Included on the CD, it contains information
about acoustic output and patient-applied part temperatures.
•Medical Ultrasound Safety: Included on the CD, it contains information
on bioeffects and biophysics, prudent use, and implementing ALARA (as
low as reasonably achievable).
•Shared Roles for System and Data Security: Included on the CD, it
contains guidelines to help you understand how the security of your Philips
product could be compromised and information on Philips efforts to help
you prevent security breaches.
•Media Compatibility: Included on the CD, it contains current information
on media that are compatible with your system.
Product Conventions
Your Philips product uses certain conventions throughout the interface to make
it easy for you to learn and use:
20
•Two unlabeled buttons, referred to as "Select controls," are used with the
trackball. Those controls, located on either side of the trackball, operate
somewhat similarly to PC mouse buttons. Both Select controls function
identically.
•Tabs along the top of the monitor display let you choose additional sets of
setup options. Tabs along the top of the touch screen let you choose
additional pages of controls.
•To type text into a text field, click in the field and use the keyboard.
•
To display a list, click the down arrow. To scroll through a list, click the
arrows at either end of the scroll bar or drag the scroll box up or down.
•Controls on the control panel include buttons, knobs, slide controls, and
a trackball. Press a button to activate or deactivate its function. Turn a knob
to change the selected setting. Press a knob-button to activate its function,
or turn it to change the selected setting. Move a slide control to change its
setting. Roll the trackball in the direction that you want to move an object.
iU22 User Manual
4535 614 45861
Read This First
1
The current trackball function is displayed in the trackball select menu at
the bottom of the display.
•Controls on the touch screen include buttons and knobs. To use a touch
screen button, simply touch it. To use a touch screen knob, adjust the
corresponding knob below the knob display (located in the bottom row of
the touch screen).
•Many tabs on the touch screen contain two pages of controls. Touch Next
and Previous to display these pages.
•Controls on the touch screen use several methods to indicate their status.
Buttons that are either on or off have an indicator in the upper corner that
lights when it is on. Buttons that select a setting generally display the active
setting either within the button or on the monitor display. An arrow in the
lower right corner of a button indicates that the button displays or hides
a group of related buttons. Where only one button in a group can be
selected at a time, the selected button is indicated by a gold outline or
background. For more information, see "Touch Screen Controls" on page
135.
User Information Conventions
The user information for your product uses the following typographical
conventions to assist you in finding and understanding information:
•All procedures are numbered, and all subprocedures are lettered. You must
complete steps in the sequence they are presented to ensure success.
•Bulleted lists indicate general information about a particular function or
procedure. They do not imply a sequential procedure.
•Control names and menu items or titles are spelled as they are on the
system, and they appear in bold text. The only exceptions are the trackball
and the buttons adjacent to it, which are unlabeled.
•Symbols appear as they appear on the system.
•The pointer is the cursor used to select elements on the display. Use the
Pointer control to display the pointer.
•Point means to position the tip of the pointer or cursor on an item on the
display.
iU22 User Manual
4535 614 45861
21
Read This First
1
•Click or select means to move the pointer or cursor to an object and press
one of the unlabeled Select buttons located on either side of the trackball.
•Double-click means to quickly click twice to select an object or text.
•Drag means to place the pointer over an object and then press and hold
one of the Select buttons while moving the trackball. Use this method to
move an object on the display.
•Touch means to press a button on the touch screen, located above the
control panel.
•Selecting means to specify an image or thumbnail to be exported or deleted.
To select an image, either click on the thumbnail or the thumbnail number.
•Highlighting means to mark an image you want to reject during a protocol
exam or an image you want to post-process. To highlight an image, click
inside the image (but not on the number).
•The left side of the system is to your left as you stand in front of the system,
facing the system. The front of the system is nearest to you as you operate
it.
•Transducers and pencil probes both are referred to as transducers, unless
the distinction is important to the meaning of the text.
Information that is essential for the safe and effective use of your product appears
throughout your user information as follows:
WARNING
Warnings highlight information vital to the safety of you, the operator, and the
patient.
CAUTION
Cautions highlight ways that you could damage the product and consequently
void your warranty or service contract or ways that you could lose patient or
system data.
NOTE
Notes bring your attention to important information that will help you operate
the product more effectively.
22
iU22 User Manual
4535 614 45861
Upgrades and Updates
Philips is committed to innovation and continued improvement. Upgrades may
be announced that consist of hardware or software improvements. Updated
user information will accompany those upgrades.
Customer Comments
If you have questions about the user information, or you discover an error in
the user information, in the USA, please call Philips Ultrasound Customer Service
at 800-722-9377; outside the USA, please call your local customer service
representative.
Supplies and Accessories
To order ECG trunk cables, lead sets, and electrodes; transducer covers; biopsy
guides; and other supplies and accessories, contact CIVCO Medical Solutions:
Read This First
1
NOTE
CIVCO Medical Solutions
102 First Street South, Kalona, IA 52247-9589
Telephone: 800-445-6741 (USA and Canada), +1 319-656-4447 (International)
Fax: 877-329-2482 (USA and Canada), +1 319-656-4451 (International)
E-mail: info@civco.com
Internet: www.civco.com
Model or part numbers in the following tables are subject to change.
iU22 User Manual
4535 614 45861
23
1
Read This First
System Accessories
Model/Part
NumberAccessory
Description
Transducer covers
610-748Tip guards
610-945
610-840
610-860
610-933
–ECG cables and lead sets
See "Approved Cables for
Electromagnetic Compliance" on
page 71
Pre-gelled snap electrode40420AECG electrode
Transducer tip protector for
most TEE transducers
Transducer tip protector for T6H
and S7-2omni
Bite guard for TEE transducersM2203ABite guard
Pediatric bite block610-979Bite blocks
Bite block without strap610-160
Bite block with strap610-749
Protective sheath for TEE
transducers
24
iU22 User Manual
4535 614 45861
610-836
610-843
610-010
610-214
610-797
610-833
Protective sheath for endocavity
transducers
Intraoperative protective sheath
for L15-7io transducers
Covers for noninvasive or
noncavity transducers
Model/Part
NumberAccessory
Read This First
Description
1
–Cables
See "Approved Cables for
Electromagnetic Compliance" on
page 71
–Printers
See "External Printers" on page
108
Optional foot switch989605344671Foot switch
–VCRs
See "Approved Accessories for
Electromagnetic Compliance" on
page 73
–DVD recorders
See "Approved Accessories for
Electromagnetic Compliance" on
page 73
See the following table–Biopsy guides
–Transducers
See "Clinical Options and
Transducers" on page 196
–Removable media
See "Media Compatibility" on page
166
Transducer
Biopsy Guides
Compatible Biopsy
Guide Model
9896053510913D9-3v
989605369041C5-1
989605341511C5-2
iU22 User Manual
4535 614 45861
25
1
Read This First
Transducer
Compatible Biopsy
Guide Model
8500-8180-02C8-4v
989605341521C8-5
8500-1290-01C9-4
8500-1704-01C9-5ec
8500-8180-02C10-3v
8500-9089-03L12-5 50 mm
989605341541L17-5
989605352591L9-3
989605341531S4-1
989605377711VL13-5
989605361851X3-1
453561442341X6-1
Customer Service
Customer service representatives are available worldwide to answer questions
and to provide maintenance and service. Please contact your local Philips
Ultrasound representative for assistance. You can also contact one of the
following offices for referral to a customer service representative, or visit the
Philips Ultrasound Web site:
www.philips.com/ultrasound
Corporate and North American Headquarters
22100 Bothell-Everett Highway, Bothell, WA 98021-8431, USA
800-722-9377
26
iU22 User Manual
4535 614 45861
Asia Pacific Headquarters
Level 9, Three Pacific Place, 1 Queen's Road East, Wanchai, Hong Kong
+852 2821 5888
European Headquarters (also serves Africa and the Middle East)
Philips Medizin Systeme Böblingen GmbH
Hewlett-Packard-Str. 2, 71034 Böblingen, Germany
+49 40 5078 4532
Latin American Headquarters
1550 Sawgrass Corporate Parkway, Suite 300, Sunrise, FL 33323, USA
+1 954-628-1000
WEEE Recycling Information
Read This First
1
The European Union Directive on Waste Electrical and Electronic Equipment
(WEEE) requires producers of electrical and electronic equipment to provide
reuse and treatment information for each product. This information is provided
in a Philips Healthcare Recycling Passport. Such "recycling passports" for Philips
Ultrasound systems are available on this Web site:
Please read this information before using your ultrasound system. It applies to
the ultrasound system, transducers, recording devices, and any optional
equipment. This section covers general safety information only. Safety
information that applies only to a specific task is included in the procedure for
that task.
This device is intended for use by, or by the order of, and under the supervision
of a licensed physician qualified to direct the use of the device.
A WARNING describes precautions necessary to prevent injury or loss of
life.
A CAUTION describes precautions necessary to protect the equipment and
patient or system data.
Electrical Safety
This equipment has been verified by a recognized third-party testing agency
as a Class I device with Type BF and Type CF isolated patient-applied parts,
and Type B non-isolated patient-applied parts. (The safety standards met by
this system are included in the "Specifications" section.) For maximum safety
observe these warnings and cautions:
WARNINGS
•Shock hazards may exist if this system, including all externally mounted
recording and monitoring devices, is not properly grounded. Protection
against electrical shock is provided by grounding the chassis with a
iU22 User Manual
4535 614 45861
29
30
Safety
2
three-wire cable and plug. The system must be plugged into a grounded
outlet. The grounding wire must not be removed or defeated.
•To avoid the risk of electrical shock, never connect the system power cord
to a power strip or an extension cord. When using the power cord, always
connect it directly to a grounded wall outlet.
•Because Type B and BF transducers are not isolated and have a higher
inherent leakage current, those transducers are not intended for invasive
use.
•Do not remove the protective covers on the system; hazardous voltages
are present inside. Cabinet panels must be in place while the system is in
use. All internal adjustments and replacements must be made by a qualified
Philips Ultrasound field service engineer.
•Do not operate this system in the presence of flammable gases or
anesthetics. Explosion can result. The system is not compliant in AP/APG
environments as defined by IEC 60601-1.
•To avoid risk of electrical shock hazards, always inspect the transducer
before use: Check the face, housing, and cable before use. Do not use if
the face is cracked, chipped, or torn; the housing is damaged; or the cable
is abraded.
•To avoid risk of electrical shock hazards, always turn off the system and
disconnect it from the wall outlet before cleaning the system.
•All patient-contact devices, such as transducers, pencil probes, and ECG
leads not specifically indicated as defibrillation-proof must be removed from
patient contact before application of a high-voltage defibrillation pulse. See
"Defibrillators" on page 32.
•During transesophageal echocardiographic (TEE) procedures, either remove
the TEE transducer from the patient or disconnect the TEE transducer from
the system immediately following image acquisition.
•Ultrasound equipment in normal operation, as with other medical electronic
diagnostic equipment, uses high-frequency electrical signals that can interfere
with pacemaker operation. Though the possibility of interference is slight,
be alert to this potential hazard and stop system operation immediately if
you note interference with a pacemaker.
•When using additional peripheral equipment powered from an electrical
source other than the ultrasound system, the combination is considered
iU22 User Manual
4535 614 45861
Safety
2
to be a medical system. It is your responsibility to comply with IEC 60601-1
and test the system to those requirements. If you have questions, contact
your Philips representative.
•Do not use nonmedical peripherals, such as report printers, within 1.5 m
(5 ft) of a patient, unless the nonmedical peripherals receive power from
an isolated power outlet on the Philips ultrasound system, or from an
isolation transformer that meets medical safety standards, as defined by
standard IEC 60601-1.
•The system and patient-applied parts meet the standard IEC 60601-1.
Applied voltages exceeding the standard, although unlikely, may result in
electrical shock to the patient or operator.
•Connection of optional devices not supplied by Philips Ultrasound could
result in electrical shock. When such optional devices are connected to
your ultrasound system, ensure that the total system earth leakage current
does not exceed 500 µA, or in the United States, 300 µA.
•To avoid risk of electrical shock, do not use any transducer that has been
immersed beyond the specified cleaning or disinfection level. See the
"Transducer Care" section.
•To avoid risks of electrical shock and fire hazards, inspect the system power
cord and plug regularly. Ensure that they are not damaged in any way.
•Operating the system with physio input signals that are below the specified
minimum levels may cause inaccurate results. See the "Specifications" section.
•Electrosurgical units (ESUs) and other devices intentionally introduce radio
frequency electromagnetic fields or currents into patients. Because imaging
ultrasound frequencies are coincidentally in the radio frequency range,
ultrasound transducer circuits are susceptible to radio frequency
interference. While an ESU is in use, severe noise interferes with the
black-and-white image and completely obliterates the color image.
Concurrent failures in an ESU or other device and in the outer layer of the
TEE transducer shaft can cause electrosurgical currents to return along the
transducer conductors. This could burn the patient, and the ultrasound
system and the transducer could also be damaged. Be aware that a disposable
transducer cover provides no protective electrical insulation at ESU
frequencies.
iU22 User Manual
4535 614 45861
31
Safety
2
•To avoid risk of a burn hazard, do not use transducers with high-frequency
•Using cables, transducers, and accessories other than those specified for
CAUTIONS
•Although your system has been manufactured in compliance with existing
•For information on electromagnetic emissions and immunity as it applies
surgical equipment. A burn hazard may result from a defect in the
high-frequency surgical neutral electrode connection.
use with the system may result in increased emissions from, or decreased
immunity of, the system.
EMI/EMC requirements, use of this system in the presence of an
electromagnetic field can cause momentary degradation of the ultrasound
image. When interference is present or intermittent, use caution when
continuing to use the system. If interference occurs often, review the
environment in which the system is being used, to identify possible sources
of radiated emissions. These emissions could be from other electrical devices
used within the same room or an adjacent room. Communication devices
such as cellular phones and pagers can cause these emissions. The existence
of radio, TV, or microwave transmission equipment located nearby can
cause emissions. In cases where EMI is causing disturbances, it may be
necessary to relocate your system.
to the system, see "Electromagnetic Compatibility" on page 67. Ensure that
the operating environment of your system meets the conditions specified
in the referenced information. Operating the system in an environment that
does not meet those conditions may degrade system performance.
Debrillators
Observe the following warnings when using a transducer when a defibrillation
is required.
32
iU22 User Manual
4535 614 45861
WARNINGS
•Before defibrillation, always remove the transducer from the patient.
•Before defibrillation, always disconnect the transducer from the system.
•A disposable transducer cover provides no protective electrical insulation
against defibrillation.
•A small hole in the outer layer of the transducer opens a conductive path
to grounded metal parts of the transducer. The secondary arcing that could
occur during defibrillation could cause patient burns. The risk of burns is
reduced, but not eliminated, by using an ungrounded defibrillator.
Use defibrillators that do not have grounded patient circuits. To determine
whether or not a defibrillator patient circuit is grounded, see the defibrillator
service guide, or consult a biomedical engineer.
Mechanical Safety
A list of precautions related to mechanical safety follows; observe these
precautions when using the system:
Safety
2
WARNINGS
•Be aware of the wheels on the system cart, especially when moving the
•When attempting to overcome an obstacle, do not push the system from
•Position external hardcopy devices away from the system. Ensure that they
•When positioning the monitor, move it carefully to avoid pinching hands
•Never park the system on an incline.
•The brakes are intended as a convenience. To increase cart security, use
•If system operation is abnormal after you move or transport the system,
system. The system could cause injury to you or others if it rolls over feet
or into shins. Use caution when going up or down ramps.
either side with excessive force, which could cause the system to tip over.
are secure. Do not stack them on the system.
or extremities against other objects, such as a bed rail.
wheel chocks when the system is parked.
contact Philips Ultrasound Customer Service immediately. System
iU22 User Manual
4535 614 45861
33
Safety
2
•Before moving the system, ensure that the keyboard is retracted, the control
CAUTIONS
•Before moving the system, ensure that the system is secured for transport.
•Ensure that the cables for all patient-applied parts are secure before moving
•Do not roll the system over transducer cables or power cables.
components are installed securely and can withstand considerable shock,
but excessive shock can cause a system failure.
panel is centered, and the monitor is locked (see "Positioning the Control
Module" on page 134 and "Preparing and Moving" on page 117). When
extended, the keyboard might be damaged if it hits another object, and the
video monitor could swing out during transport, causing injury or equipment
damage.
On some systems, that may include ensuring that the monitor is latched,
to prevent monitor damage during transport.
the system. Use the cable management system to ensure that transducer
cables are protected from damage.
Equipment Protection
Follow these precautions to protect your system:
CAUTIONS
•Excessive bending or twisting of cables on patient-applied parts may cause
failure or intermittent operation of the system. Do not roll the system over
cables, which may damage them.
•Improper cleaning or sterilization of a patient-applied part may cause
permanent damage. For cleaning and disinfection instructions, see the
"Transducer Care" section.
•Do not submerge the cables of patient-applied parts in solution. The cables
are not liquid-tight beyond the applied part/cable or cable/connector
interfaces.
34
iU22 User Manual
4535 614 45861
Safety
2
•In general, only the area of the transducer acoustic window is liquid-tight.
Except where specified in specific transducer-cleaning instructions, do not
immerse the remainder of a transducer in any liquid.
•Do not use solvents, such as thinner or benzine, or abrasive cleaners on
the system, transducers, or any hardcopy device.
•For optimal performance, connect your ultrasound system to a circuit
dedicated solely for the system. Do not connect life-support devices to the
same circuit as the ultrasound system.
•If systems, transducers, and peripherals have been in an environment below
10°C (50°F), allow them to reach room temperature before connecting or
turning them on. Philips recommends allowing 24 hours for complete
normalization. Otherwise, condensation inside the devices could cause
damage. If the device was only briefly exposed to temperatures below 10°C
(50°F), then the time required for the device to return to room temperature
could be significantly less than 24 hours.
•To avoid damaging the flat-panel display in the monitor, do not store the
system where the ambient temperature exceeds 65°C (149°F).
Symbols
The International Electrotechnical Commission (IEC) has established a set of
symbols for medical electronic equipment that classify a connection or warn of
potential hazards. Of those symbols, the following may be used on your Philips
product and its accessories and packaging.
Non-isolated patient connection (Type B applied
part).
Isolated patient connection for applied part intended
for intraoperative use, including direct cardiac
application and contact with major vessels (Type CF
applied part).
Identifies ESD (electrostatic-discharge) sensitivity of
a connector that is not tested as specified in
IEC 60601-1-2. Do not touch exposed connector
pins. Touching exposed pins can cause electrostatic
discharge, which can damage the product.
Identifies an On/Off control.
36
On a two-position power switch, represents On and
Off.
Identifies a safety note.
Indicates that the user should see the instructions
for use for safety information.
iU22 User Manual
4535 614 45861
Safety
2
Identifies equipotential ground.
Identifies earth ground.
Identifies protective earth ground.
Nonionizing electromagnetic radiation. Indicates that
interference may occur in the vicinity of equipment
marked with this symbol.
The radio component contained in this device is
compliant to Council Directive 1999/5/EC (Radio
Equipment and Telecommunications Terminal
Equipment Directive).
Class 2 radio equipment identifier per Directive
1999/5/EC. European Union member states may apply
restrictions on putting this device into service or
placing it on the market. This device is intended to
be connected to the Publicly Available Interfaces for
use throughout the European Economic Area.
Indicates that the device is protected against the
effects of vertically falling water. This degree of
protection can apply to transducers or foot-operated
devices.
Indicates that the device is protected against the
effects of splashing liquids. This degree of protection
can apply to foot-operated devices.
iU22 User Manual
4535 614 45861
37
Safety
2
Indicates that the device is protected against the
effects of immersion. This degree of protection can
apply to transducers and foot-operated devices.
Indicates that the device is protected against the
effects of immersion for up to 60 minutes. This
degree of protection can apply to foot-operated
devices.
Indicates the need for separate collection for
electrical and electronic equipment in compliance
with the Waste Electrical and Electronic Equipment
(WEEE) Directive. When accompanied byor,
components of the device may contain lead or
mercury, respectively, which must be recycled or
disposed of in accordance with local, state, or federal
laws. The backlight lamps in an LCD system monitor
contain mercury.
Do not throw away. Dispose of in accordance with
local, state, or federal laws.
38
Do not reuse.
Use-by date.
iU22 User Manual
4535 614 45861
Safety
2
Global Medical Device Nomenclature Code.
Indicates a possible crushing hazard to hands.
Warns that the system should not be used stacked
with other equipment. If the system is used stacked
with or adjacent to other equipment, verify normal
operation before use.
Indicates the temperature range (noncondensing) for
transport and storage. (Does not apply to media.)
Indicates the atmospheric pressure range for
transport and storage.
Indicates the relative humidity range (noncondensing)
for transport and storage.
Indicates that a connector receives alternating
current.
Identifies fuse boxes or their locations. For continued
protection from fire and shock, replace fuses only
with fuses of the same type and rating.
iU22 User Manual
4535 614 45861
39
Safety
2
Identifies the date of manufacture.
Identifies the legal manufacturer.
This side up: Points toward the side of the shipping
crate that should be kept facing up.
Indicates that the device should be kept dry.
Indicates that the device is fragile; handle with care.
Warns of system over-balance due to external force.
(Do not push on the monitor to move the system.)
40
Keep away from sunlight.
Non-sterile.
Sterilized using ethylene oxide.
iU22 User Manual
4535 614 45861
Safety
2
Catalog number.
Batch code.
Serial number.
Universal part number.
The following symbols may also be used on the system and its accessories and
packaging:
Connection for a pencil probe
Connection for a pencil probe
Connection for a transducer
Connection for ECG leads
Connection for ECG leads
Connection for ECG leads
iU22 User Manual
4535 614 45861
41
Safety
2
Print remote output
Input port for audio left/right, VHS/S-VHS,
microphone, CD, or DVD
Output port for audio left/right, VHS/S-VHS, video
patient monitor, black-and-white printer, or
interlaced RGB output port
VGA or parallel output port
DVI video output receptacle
USB input/output port
42
Ethernet connection
System microphone
Isolated auxiliary power provided for connection of
Philips-approved remote accessories
iU22 User Manual
4535 614 45861
Safety
Foot switch
Indicates the atmospheric pressure range for
transport and storage.
SVGA connection
Two video receptacles provide DVI-D digital video
for flat-panel monitors.
S-Video connection
B/W Composite video output connection
Color composite video output connection
2
Video print trigger connection
Russian approval (GOST)
The following symbols may be used inside the system:
Dangerous voltages: Appears adjacent to high-voltage
terminals, indicating the presence of voltages greater
than 1,000 Vac (600 Vac in the United States).
Indicates equipotential ground.
iU22 User Manual
4535 614 45861
43
Safety
2
Biological Safety
This section contains information about biological safety and a discussion of the
prudent use of the system.
A list of precautions related to biological safety follows; observe these precautions
when using the system. For more information refer to Medical Ultrasound Safety
on your user information CD.
WARNINGS
•Do not use the system if an error message on the video display indicates
that a hazardous condition exists. Note the error code, turn off power to
the system, and call your customer service representative.
•Do not use a system that exhibits erratic or inconsistent image updating.
Discontinuities in the scanning sequence indicate a hardware failure that
must be corrected before use.
•Perform ultrasound procedures prudently. Use the ALARA (as low as
reasonably achievable) principle.
•Use only acoustic standoffs that have been approved by Philips Ultrasound.
For information on ordering approved accessories, see "Supplies and
Accessories" on page 23.
•Verify the alignment of the biopsy guide before use. See the "Biopsy Guides"
section.
•Verify the condition of the biopsy needle before use. Do not use a bent
biopsy needle.
•Transducer covers may contain natural rubber latex. Those covers may
cause allergic reactions in some individuals. See "FDA Medical Alert on
Latex" on page 45.
•In contrast studies using a high-MI acoustic field, capillary rupture, due to
microbubble expansion within a capillary in an acoustic field, can cause
extravasation. References: (1) Skyba, D.M., Price, R.J., Linka, A.Z., Skalak,
T.C., Kaul, S. "Direct in vivo visualization of intravascular destruction of
microbubbles by ultrasound and its local effects on tissue." Circulation, 1998;
98:290-293. (2) van Der Wouw, P.A., Brauns, A.C., Bailey, S.E., Powers, J.E.,
44
iU22 User Manual
4535 614 45861
Safety
2
Wilde, A.A. "Premature ventricular contractions during triggered imaging
with ultrasound contrast." Journal of the American Society of Echocardiography,
2000;13(4):288-94.
•Preventricular contractions can be caused by the oscillations of microbubbles
when a high-MI acoustic field is triggered in the heart at the end of systole.
In a very sick patient with certain risk factors, theoretically, this could lead
to ventricular fibrillation. Reference: van Der Wouw, P.A., Brauns, A.C.,
Bailey, S.E., Powers, J.E., Wilde, A.A. "Premature ventricular contractions
during triggered imaging with ultrasound contrast." Journal of the AmericanSociety of Echocardiography, 2000;13(4):288-94.
•If a sterile transducer cover becomes compromised during an intraoperative
application involving a patient with transmissible spongiform encephalopathy,
such as Creutzfeldt-Jakob disease, follow the guidelines of the U.S. Centers
for Disease Control and this document from the World Health Organization:
WHO/CDS/ APH/2000/3, WHO Infection Control Guidelines for
Transmissible Spongiform Encephalopathies. The transducers for your
system cannot be decontaminated using a heat process.
•If the system becomes contaminated internally with bodily fluids carrying
pathogens, you must immediately notify your Philips service representative.
Components inside the system cannot be disinfected. In that case, the
system must be disposed of as biohazardous material in accordance with
local or federal laws.
•The backlight lamps in the system displays contain mercury and must be
recycled or disposed of according to local, state, or federal laws.
•Select the correct application when starting an exam, and remain in that
application throughout the exam. Some applications are for parts of the
body that require lower limits for acoustic output. One example is the
ophthalmic application, which is activated by selecting a Tissue Specific
preset such as Orbital TCD. When performing an ophthalmic exam, use
only an ophthalmic preset.
FDA Medical Alert on Latex
March 29, 1991, Allergic Reactions to Latex-Containing Medical Devices
iU22 User Manual
4535 614 45861
45
Safety
2
Because of reports of severe allergic reactions to medical devices containing
latex (natural rubber), the FDA is advising health care professionals to identify
their latex sensitive patients and be prepared to treat allergic reactions promptly.
Patient reactions to latex have ranged from contact urticaria to systemic
anaphylaxis. Latex is a component of many medical devices, including surgical
and examination gloves, catheters, intubation tubes, anesthesia masks, and dental
dams.
Reports to the FDA of allergic reactions to latex-containing medical devices have
increased lately. One brand of latex cuffed enema tips was recently recalled after
several patients died as a result of anaphylactoid reactions during barium enema
procedures. More reports of latex sensitivity have also been found in the medical
literature. Repeated exposure to latex both in medical devices and in other
consumer products may be part of the reason that the prevalence of latex
sensitivity appears to be increasing. For example, it has been reported that 6%
to 7% of surgical personnel and 18% to 40% of spina bifida patients are latex
sensitive.
Proteins in the latex itself appear to be the primary source of the allergic
reactions. Although it is not now known how much protein is likely to cause
severe reactions, the FDA is working with manufacturers of latex-containing
medical devices to make protein levels in their products as low as possible.
46
FDA’s recommendations to health professionals in regard to this problem are
as follows:
•When taking general histories of patients, include questions about latex
sensitivity. For surgical and radiology patients, spina bifida patients and health
care workers, this recommendation is especially important. Questions about
itching, rash or wheezing after wearing latex gloves or inflating a toy balloon
may be useful. Patients with positive histories should have their charts
flagged.
•If latex sensitivity is suspected, consider using devices made with alternative
materials, such as plastic. For example, a health professional could wear a
non-latex glove over the latex glove if the patient is sensitive. If both the
health professional and the patient are sensitive, a latex middle glove could
iU22 User Manual
4535 614 45861
Safety
2
be used. (Latex gloves labeled “Hypoallergenic” may not always prevent
adverse reactions.)
•Whenever latex-containing medical devices are used, especially when the
latex comes in contact with mucous membranes, be alert to the possibility
of an allergic reaction.
•If an allergic reaction does occur and latex is suspected, advise the patient
of a possible latex sensitivity and consider an immunologic evaluation.
•Advise the patient to tell health professionals and emergency personnel
about any known latex sensitivity before undergoing medical procedures.
Consider advising patients with severe latex sensitivity to wear a medical
identification bracelet.
The FDA is asking health professionals to report incidents of adverse reactions
to latex or other materials used in medical devices. (See the October 1990 FDA
Drug Bulletin.) To report an incident, call the FDA Problem Reporting Program,
operated through the U.S. Pharmacopoeia toll-free number: 800-638-6725. (In
Maryland, call collect 301-881-0256.)
For a single copy of a reference list on latex sensitivity, write to: LATEX, FDA,
HFZ-220, Rockville, MD 20857.
NOTE
The ultrasound system and transducers described in this document do not
contain natural rubber latex that contacts humans. Natural rubber latex is not
used on any Philips ultrasound transducer. It also is not used on Philips ECG
cables for the products described in this document.
ALARA Education Program
The guiding principle for the use of diagnostic ultrasound is defined by the "as
low as reasonably achievable" (ALARA) principle. The decision as to what is
reasonable has been left to the judgment and insight of qualified personnel. No
set of rules can be formulated that would be sufficiently complete to dictate the
correct response to every circumstance. By keeping ultrasound exposure as low
as possible, while obtaining diagnostic images, users can minimize ultrasonic
bioeffects.
iU22 User Manual
4535 614 45861
47
Safety
2
Since the threshold for diagnostic ultrasound bioeffects is undetermined, it is
the sonographer’s responsibility to control total energy transmitted into the
patient. The sonographer must reconcile exposure time with diagnostic image
quality. To ensure diagnostic image quality and limit exposure time, an ultrasound
system provides controls that can be manipulated during the exam to optimize
the results of the exam.
The ability of the user to abide by the ALARA principle is important. Advances
in diagnostic ultrasound, not only in the technology but in the applications of
that technology, have resulted in the need for more and better information to
guide the user. The output display indices are designed to provide that important
information.
There are a number of variables which affect the way in which the output display
indices can be used to implement the ALARA principle. These variables include
index values, body size, location of the bone relative to the focal point, attenuation
in the body, and ultrasound exposure time. Exposure time is an especially useful
variable, because it is controlled by the user. The ability to limit the index values
over time supports the ALARA principle.
48
Applying ALARA
The system imaging mode used depends upon the information needed. 2D and
M-mode imaging provide anatomical information, while Doppler, Color Power
Angio (CPA), and Color imaging provide information about blood flow. A scanned
mode, like 2D or Color, disperses or scatters the ultrasonic energy over an area,
while an unscanned mode, like M-mode or Doppler, concentrates ultrasonic
energy. Understanding the nature of the imaging mode being used allows the
sonographer to apply the ALARA principle with informed judgment. Additionally,
the transducer frequency, system setup values, scanning techniques, and operator
experience allow the sonographer to meet the definition of the ALARA principle.
The decision as to the amount of acoustic output is, in the final analysis, up to
the system operator. This decision must be based on the following factors: type
of patient, type of exam, patient history, ease or difficulty of obtaining
diagnostically useful information, and the potential localized heating of the patient
due to transducer surface temperatures. Prudent use of the system occurs when
iU22 User Manual
4535 614 45861
Safety
2
patient exposure is limited to the lowest index reading for the shortest amount
of time necessary to achieve acceptable diagnostic results.
Although a high index reading does not mean that a bioeffect is actually occurring,
a high index reading should be taken seriously. Every effort should be made to
reduce the possible effects of a high index reading. Limiting exposure time is an
effective way to accomplish this goal.
There are several system controls that the operator can use to adjust the image
quality and limit the acoustic intensity. These controls are related to the
techniques that an operator might use to implement ALARA. These controls
can be divided into three categories: direct, indirect, and receiver controls.
Acoustic Output Limits
This ultrasound system maintains acoustic output below the appropriate limits
for each application, as listed here. The significant difference in magnitude
emphasizes the need to select the correct application and remain in that
application, so the correct application limits are in use for the appropriate
application.
Limits for Non-Ophthalmic Applications
•I
≤ 720 mW/cm
spta.3
2
•MI ≤ 1.9
•TI ≤ 6.0
Limits for Ophthalmic Applications
•I
≤ 50 mW/cm
spta.3
2
•MI ≤ 0.23
•TI ≤ 1.0
Direct Controls
Application selection and the output-power control directly affect acoustic
intensity. There are different ranges of allowable intensity or output based on
your selection. Selecting the correct range of acoustic intensity for the application
is one of the first things that occurs in any exam. For example, peripheral vascular
intensity levels are not recommended for fetal exams. Some systems automatically
iU22 User Manual
4535 614 45861
49
Safety
2
select the proper range for a particular application, while others require manual
selection. Ultimately, the user has the responsibility for proper clinical use. The
ultrasound system provides both automatic (default) settings and manual
(user-selectable) settings.
Output power has direct impact on acoustic intensity. Once the application has
been established, the power control can be used to increase or decrease the
intensity output. The power control allows you to select intensity levels less
than the established maximum. Prudent use dictates that you select the lowest
output intensity that is consistent with good image quality.
Indirect Controls
The indirect controls are those that have an indirect effect on acoustic intensity.
These controls affect imaging mode, pulse repetition frequency, focus depth,
pulse length, and transducer selection.
The choice of imaging mode determines the nature of the ultrasound beam. 2D
is a scanning mode; Doppler is a stationary or unscanned mode. A stationary
ultrasound beam concentrates energy in a single location. A moving or scanned
ultrasound beam disperses the energy over an area and the beam is concentrated
on the same area for a fraction of the time as that of an unscanned mode.
50
Pulse repetition frequency or rate refers to the number of ultrasound bursts of
energy over a specific period of time. The higher the pulse repetition frequency,
the more pulses of energy in a period of time. Several controls affect pulse
repetition frequency: focal depth, display depth, sample volume depth, flow
optimization, scale, number of focal zones, and sector-width controls.
Focus of the ultrasound beam affects the image resolution. To maintain or
increase resolution at a different focus requires a variation in output over the
focal zone. This variation of output is a function of system optimization. Different
exams require different focal depths. Setting the focus at the proper depth
improves the resolution of the structure of interest.
Pulse length is the time during which the ultrasonic burst is turned on. The longer
the pulse, the greater the time-average intensity value. The greater the
time-average intensity, the greater the likelihood of temperature increase and
cavitation. Pulse length, burst length, or pulse duration is the output pulse
iU22 User Manual
4535 614 45861
Safety
2
duration in PW Doppler. Increasing the Doppler sample-volume size increases
the pulse length.
Transducer selection indirectly affects intensity. Tissue attenuation changes with
frequency. The higher the transducer operating frequency, the greater the
attenuation of the ultrasonic energy. A higher transducer operating frequency
requires more output intensity to scan at a deeper depth. To scan deeper at the
same output intensity, a lower transducer frequency is required. Using more
gain and output beyond a point, without corresponding increases in image quality,
can mean that a lower frequency transducer is needed.
Receiver Controls
Receiver controls are used by the operator to improve image quality. These
controls have no effect on output. Receiver controls only affect how the
ultrasound echo is received. These controls include gain, TGC, dynamic range,
and image processing. The important thing to remember, relative to output, is
that receiver controls should be optimized before output is increased. For
example, before increasing output, optimize gain to improve image quality.
An Example of Applying the ALARA Principle
An ultrasound scan of a patient’s liver begins with selecting the appropriate
transducer frequency. After selecting the transducer and the application, which
are based on patient anatomy, adjustments to output power should be made to
ensure that the lowest possible setting is used to acquire an image. After the
image is acquired, adjusting the focus of the transducer, and then increasing the
receiver gain to produce a uniform representation of the tissue follows. If an
adequate image can be obtained with the increase in gain, then a decrease in
output should be made. Only after making these adjustments should you increase
output to the next level.
Having acquired the 2D display of the liver, Color can be used to localize blood
flow. As with the 2D image display, gain and image processing controls must be
optimized before increasing output.
Having localized the blood flow, use the Doppler controls to position the sample
volume over the vessel. Before increasing output, adjust velocity range or scale
iU22 User Manual
4535 614 45861
51
Safety
2
and Doppler gain to obtain an optimal Doppler trace. Only if maximum Doppler
gain does not create an acceptable image do you increase output.
In summary: Select the correct transducer frequency and application for the job;
start with a low output level; and optimize the image by using focus, receiver
gain, and other imaging controls. If the image is not diagnostically useful at this
point, then increase output.
Additional Considerations
Ensure that scanning time is kept to a minimum, and ensure that only medically
required scanning is performed. Never compromise quality by rushing through
an exam. A poor exam may require a follow-up, which ultimately increases
exposure time. Diagnostic ultrasound is an important tool in medicine, and like
any tool, it should be used efficiently and effectively.
Output Display
The system output display comprises two basic indices: a mechanical index and
a thermal index. The thermal index further consists of the following indices: soft
tissue (TIS), bone (TIB), and cranial bone (TIC). One of these three thermal
indices will be displayed at all times. Which one depends upon the system preset
or user choice, depending upon the application at hand.
52
The mechanical index is continuously displayed over the range of 0.0 to 1.9, in
increments of 0.1.
The thermal index comprises three indices, and only one of these is displayed
at any one time. Each transducer application has a default selection that is
appropriate for that combination. The TIB, TIS, or TIC is continuously displayed
over the range of 0.0 to maximum output, based on the transducer and
application, in increments of 0.1. For the location of the output display, see
"Imaging Display" on page 159.
The application-specific nature of the default setting is also an important factor
of index behavior. A default setting is a system control state that is preset by
the manufacturer or the operator. The system has default index settings for the
transducer application. The default settings are invoked automatically by the
iU22 User Manual
4535 614 45861
Safety
2
ultrasound system when power is turned on, when new patient data is entered
into the system data base, or when an application change occurs.
The decision as to which of the three thermal indices to display should be based
on the following criteria:
•Appropriate index for the application: TIS is used for imaging soft tissue,
TIB for a focus at or near bone, and TIC for imaging through bone near the
surface, as in a cranial exam.
•Mitigating factors that might create artificially high or low thermal index
readings: location of fluid or bone, or blood flow. For example, is there a
highly attenuating tissue path so that the actual potential for local zone
heating is less than the thermal index displays?
•Scanned modes versus unscanned modes of operation affect the thermal
index. For scanned modes, heating tends to be near the surface; for
unscanned modes, the potential for heating tends to be deeper in the focal
zone.
•Always limit ultrasound exposure time. Do not rush the exam. Ensure that
the indices are kept to a minimum and that exposure time is limited without
compromising diagnostic sensitivity.
Mechanical Index (MI) Display
Mechanical bioeffects are threshold phenomena that occur when a certain level
of output is exceeded. The threshold level varies, however, with the type of
tissue. The potential for mechanical bioeffects varies with peak rarefactional
pressure and ultrasound frequency. The MI accounts for these two factors. The
higher the MI value, the greater the likelihood of mechanical bioeffects occurring.
There is no specific MI value that means that a mechanical effect is actually
occurring. The MI should be used as a guide for implementing the ALARA
principle.
Thermal Index (TI) Displays
The TI informs the user about the conditions that exist that might lead to an
increase in temperature at the surface of the body, within the body tissue, or at
the point of focus of the ultrasound beam on bone. That is, the TI informs the
user of the potential for temperature rise in body tissue. It is an estimate of
iU22 User Manual
4535 614 45861
53
Safety
2
temperature increase in body tissue with specific properties. The actual amount
of any temperature rise is influenced by factors such as tissue type, vascularity,
mode of operation, and others. The TI should be used as a guide for implementing
the ALARA principle.
The bone thermal index (TIB) informs the user about potential heating at or
near the focus after the ultrasound beam has passed through soft tissue or fluid;
for example, at or near second- or third-trimester fetal bone.
The cranial bone thermal index (TIC) informs the user about the potential heating
of bone at or near the surface; for example, cranial bone.
The soft tissue thermal index (TIS) informs the user about the potential for
heating within soft homogeneous tissue.
You can choose to display TIS, TIC, or TIB. (For details on changing the TI display,
see the system Help.) On systems with transcranial applications, TIC is displayed
when you select a transcranial preset.
Mechanical and Thermal Indices Display Precision and Accuracy
54
The MI and TI precision is 0.1 unit on the system.
The MI and TI display accuracy estimates for the system are given in AcousticOutput Tables, on your user information CD. Those accuracy estimates are based
on the variability range of transducers and systems, inherent acoustic output
modeling errors, and measurement variability, as discussed in this section.
The displayed values should be interpreted as relative information to help the
system operator achieve the ALARA principle through prudent use of the system.
The values should not be interpreted as actual physical values in interrogated
tissue or organs. The initial data that is used to support the output display is
derived from laboratory measurements based on the American Institute of
Ultrasound in Medicine (AIUM) measurement standard. The measurements are
then put into algorithms for calculating the displayed output values.
Many of the assumptions used in the process of measurement and calculation
are conservative in nature. Overestimation of actual in situ intensity exposure,
iU22 User Manual
4535 614 45861
Safety
2
for the vast majority of tissue paths, is built into the measurement and calculation
process. For example:
•The measured water tank values are derated using a conservative, industry
standard, attenuation coefficient of 0.3 dB/cm-MHz.
•Conservative values for tissue characteristics were selected for use in the
TI models. Conservative values for tissue or bone absorption rates, blood
perfusion rates, blood heat capacity, and tissue thermal conductivity were
selected.
•Steady State temperature rise is assumed in the industry standard TI models,
and the assumption is made that the ultrasound transducer is held steady
in one position long enough for steady state to be reached.
A number of factors are considered when estimating the accuracy of the displayed
values: hardware variations, estimation algorithm accuracy, and measurement
variability. Variability among transducers and systems is a significant factor.
Transducer variability results from piezoelectric crystal efficiencies,
process-related impedance differences, and sensitive lens-focusing parameter
variations. Differences in system pulser voltage control and efficiencies is also a
contributor to variability. There are inherent uncertainties in the algorithms used
to estimate acoustic output values over the range of possible system operating
conditions and pulser voltages. Inaccuracies in laboratory measurements are
related to, among others, differences in hydrophone calibration and performance,
positioning, alignment, and digitization tolerances, and variability among test
operators.
The conservative assumptions of the output estimation algorithms of linear
propagation, at all depths, through a 0.3 dB/cm-MHz attenuative medium is not
considered in the accuracy estimate for the display. Neither linear propagation,
nor uniform attenuation at the 0.3 dB/cm-MHz rate, occur in water tank
measurements or in most tissue paths in the body. In the body, different tissues
and organs have dissimilar attenuation characteristics. In water, there is almost
no attenuation. In the body, and in particular, in water tank measurements,
nonlinear propagation and saturation losses occur as pulser voltages increase.
Therefore, the display accuracy estimates are based on the variability range of
transducers and systems, inherent acoustic output modeling errors, and
measurement variability. Display accuracy estimates are not based on errors in,
iU22 User Manual
4535 614 45861
55
Safety
2
or caused by measuring according to, the AIUM measurement standards, or the
effects of nonlinear loss on the measured values.
Control Effects
Controls Affecting the Indices
As various system controls are adjusted, the TI and MI values may change. This
will be most apparent as the output power control is adjusted; but other system
controls affect the on-screen output values.
Power
The output power control affects the system acoustic output. Two real-time
output values are on the display: TI and MI. They change as the system responds
to power-control adjustments.
In combined modes, such as simultaneous Color, 2D, and PW Doppler, the
individual modes each add to the total TI. One mode will be the dominant
contributor to this total. The displayed MI will be from the mode with the largest
peak pressure.
56
2D Controls
•Sector Width: Narrowing the sector angle may increase frame rate. This
action will increase the TI. Pulser voltage may be automatically adjusted
down with software controls to keep the TI below the system maximums.
A decrease in pulser voltage will decrease MI.
•Zoom: Increasing the zoom magnification by pressing Zoom may increase
frame rate. This action will increase the TI. The number of focal zones may
also increase automatically to improve resolution. This action may change
the MI, because the peak MI can occur at a different depth.
•Number of Focal Zones: More focal zones may change both the TI and
MI by changing frame rate or focal depth automatically. Lower frame rates
decrease the TI. MI displayed will correspond to the zone with the largest
MI value.
iU22 User Manual
4535 614 45861
Safety
2
•Focus: Changing the focal depth will change MI. Generally, higher MI values
will occur when the focal depth is near the natural focus of the transducer.
Color and Power Controls
•Flow Opt: Increasing the color sensitivity with the flow opt control may
increase the TI. More time is spent scanning the color image. Color pulses
are the dominant pulse type in this mode.
•Color Sector Width: Narrower color sector width will increase color
frame rate and the TI will increase. The system may automatically decrease
pulser voltage to stay below the system maximum. A decrease in pulser
voltage will decrease the MI. If PW Doppler is also enabled, then PW
Doppler will remain the dominant mode and the TI change will be small.
•Color Sector Depth: Deeper color sector depth may automatically
decrease color frame rate or select a new color focal zone or color pulse
length. The TI will change due to the combination of these effects. Generally,
the TI will decrease with increased color sector depth. MI will correspond
to the MI of the dominant pulse type which is a color pulse. However, if
PW Doppler is also enabled then PW Doppler will remain the dominant
mode and the TI change will be small.
•Scale: Using the scale control to increase the color velocity range may
increase the TI. The system may automatically adjust pulser voltage to stay
below the system maximums. A decrease in pulser voltage will also decrease
MI.
•Sector Width: A narrower 2D sector width in Color imaging will increase
color frame rate. The TI will increase. MI will not change. If PW Doppler
is also enabled, then PW Doppler will remain the dominant mode and the
TI change will be small.
M-Mode and Doppler Controls
•Simultaneous and Update Methods: Use of combination modes affects
both the TI and MI through the combination of pulse types. During
simultaneous mode, the TI is additive. During duplex, the TI will display the
iU22 User Manual
4535 614 45861
57
Safety
2
dominant pulse type. The displayed MI will be from the mode with the
largest peak pressure.
•Sample Volume Depth: When Doppler sample volume depth is increased,
the Doppler PRF may automatically decrease. An increase in PRF will
increase the TI. The system may also automatically decrease the pulser
voltage to remain below the system maximum. A decrease in pulser voltage
will decrease MI.
Other Control Effects
•Imaging Mode Controls: When a new imaging mode is selected, both
the TI and MI may change to default settings. Each mode has a corresponding
pulse repetition frequency and maximum intensity point. In combined or
simultaneous modes, the TI is the sum of the contribution from the modes
enabled, and the displayed MI is the largest of the MI values associated with
each mode and focal zone enabled. The system will return to the previously
selected state if a mode is turned off and then reselected.
•Transducer: Each transducer type has unique specifications for contact
area, beam shape, and center frequency. Defaults are initialized when you
select a transducer. Factory defaults vary with transducer, application, and
selected mode. Defaults have been chosen below the FDA limits for intended
use.
•2D Depth: An increase in 2D depth will automatically decrease the 2D
frame rate. This will decrease the TI. The system may also automatically
choose a deeper 2D focal depth. A change of focal depth may change the
MI. The MI displayed is that of the zone with the largest MI value.
•Application: Acoustic output defaults are set when you select an
application. Factory defaults vary with transducer, application, and mode.
Defaults have been chosen below the FDA limits for intended use.
58
iU22 User Manual
4535 614 45861
Related Guidance Documents
For more information about ultrasonic bioeffects and related topics, see the
following:
•"Bioeffects and Safety of Diagnostic Ultrasound." AIUM Report, January 28,
1993.
•"American Institute of Ultrasound in Medicine Bioeffects Consensus Report."
Journal of Ultrasound in Medicine, Vol. 27, Issue 4, April 2008.
•Acoustic Output Measurement Standard for Diagnostic Ultrasound
Equipment. (AIUM, NEMA, 2004)
•Second Edition of the AIUM Medical Ultrasound Safety brochure, 2009. (A
copy of this document is provided with each system.)
•Information for Manufacturers Seeking Marketing Clearance of Diagnostic
Ultrasound Systems and Transducers. FDA, September 2008.
•Standard for Real-Time Display of Thermal and Mechanical Acoustic Output
Indices on Diagnostic Ultrasound Equipment. (AIUM, NEMA, 2004)
•WFUMB. "Symposium on Safety of Ultrasound in Medicine: Conclusions
and Recommendations on Thermal and Non-Thermal Mechanisms for
Biological Effects of Ultrasound." Ultrasound in Medicine and Biology, 1998:
Vol. 24, Supplement 1.
Safety
2
Acoustic Output and Measurement
Since the initial use of diagnostic ultrasound, the possible human bioeffects from
ultrasound exposure have been studied by various scientific and medical
institutions. In October 1987, the American Institute of Ultrasound in Medicine
(AIUM) ratified a report prepared by its Bioeffects Committee ("Bioeffects
Considerations for the Safety of Diagnostic Ultrasound." Journal of Ultrasound inMedicine, Vol. 7, No. 9 Supplement, September 1988), sometimes referred to as
the Stowe Report, which reviewed available data on possible effects of ultrasound
exposure. Another report, “Bioeffects and Safety of Diagnostic Ultrasound,”
dated January 28, 1993, provides more-current information.
The acoustic output for this system has been measured and calculated in
accordance with the “Acoustic Output Measurement Standard for Diagnostic
iU22 User Manual
4535 614 45861
59
Safety
2
Ultrasound Equipment” (Revision 3, AIUM, NEMA, 2004), the “Standard for
Real-Time Display of Thermal and Mechanical Acoustic Output Indices on
Diagnostic Ultrasound Equipment” (Revision 2, AIUM, NEMA, 2004), and the
September 2008 FDA document "Information for Manufacturers Seeking
Marketing Clearance of Diagnostic Ultrasound Systems and Transducers."
In Situ, Derated, and Water Value Intensities
All intensity parameters are measured in water. Since water absorbs very little
acoustic energy, these water measurements represent a worst case value.
Biological tissue does absorb acoustic energy. The true value of the intensity at
any point depends on the amount and type of tissue and the frequency of the
ultrasound that passes through the tissue. The intensity value in the tissue, In
Situ, has been estimated by using the following formula:
In Situ = Water [e
Where:
-0.23alf
In Situ intensity value=In Situ
]
60
Water value intensity=Water
2.7183=e
Attenuation factor=a
a(dB/cm-MHz)=Tissue
0.006=Amniotic
Fluid
0.53=Brain
0.66=Heart
0.79=Kidney
0.43=Liver
0.55=Muscle
Skin line to measurement depth (cm)=l
iU22 User Manual
4535 614 45861
Safety
Center frequency of the transducer/system/mode combination
=f
2
(MHz)
Since the ultrasonic path during an examination is likely to pass through varying
lengths and types of tissue, it is difficult to estimate the true in situ intensity. An
attenuation factor of 0.3 is used for general reporting purposes; therefore, the
In Situ value which is commonly reported uses the formula:
In Situ derated = Water [e
-0.069lf
]
Since this value is not the true in situ intensity, the term “derated” is used.
Mathematical derating of water based measurements using the 0.3 dB/cm-MHz
coefficient, may yield lower acoustic exposure values than would be measured
in a homogenous 0.3 dB/cm-MHz tissue. This is true because nonlinearly
propagating acoustic energy waveforms experience more distortion, saturation,
and absorption in water than in tissue, where attenuation present all along the
tissue path will dampen the buildup of nonlinear effects.
The maximum derated and the maximum water values do not always occur at
the same operating conditions; therefore, the reported maximum water and
derated values may not be related by the in situ (derated) formula. For example:
A multi-zone array transducer that has maximum water value intensities in its
deepest zone may have its largest derated intensity in one of its shallowest focal
zones.
Conclusions Regarding Tissue Models and Equipment Survey
Tissue models are necessary to estimate attenuation and acoustic exposure
levels in situ from measurements of acoustic output made in water. Presently,
available models may be limited in their accuracy because of varying tissue paths
during diagnostic ultrasound exposures and uncertainties in acoustical properties
of soft tissues. No single tissue model is adequate for predicting exposures in
all situations from measurements made in water, and continued improvement
and verification of these models is necessary for making exposure assessments
for specific applications.
iU22 User Manual
4535 614 45861
61
Safety
2
A homogeneous tissue model with an attenuation coefficient of 0.3 dB/cm-MHz
throughout the beam path is commonly used when estimating exposure levels.
The model is conservative in that it overestimates the in situ acoustic exposure
when the path between the transducer and the site of interest is composed
entirely of soft tissue, because the attenuation coefficient of soft tissue is generally
higher than 0.3 dB/cm-MHz. When the path contains significant amounts of fluid,
as in many first- and second-trimester pregnancies scanned transabdominally,
this model may underestimate the in situ acoustical exposure. The amount of
underestimation depends on each specific situation. For example, when the beam
path is longer than 3 cm and the propagation medium is predominantly fluid
(conditions that may exist during transabdominal OB scans), a more accurate
value for the derating term is 0.1 dB/cm-MHz.
Fixed-path tissue models, in which soft tissue thickness is held constant,
sometimes are used to estimate in situ acoustical exposures when the beam path
is longer than 3 cm and consists largely of fluid. When this model is used to
estimate maximum exposure to the fetus during transabdominal scans, a value
of 1 dB/MHz may be used during all trimesters.
62
The maximum acoustic output levels of diagnostic ultrasound devices extend
over a broad range of values:
•A survey of 1990-equipment models yielded mechanical index (MI) values
between 0.1 and 1 at their highest output settings. Maximum MI values of
approximately 2 are known to occur for currently available equipment.
Maximum MI values are similar for real-time 2D, M-mode, PW Doppler,
and Color flow imaging.
•Computed estimates of upper limits to temperature elevations during
transabdominal scans were obtained in a survey of 1988 and 1990 PW
Doppler equipment. The vast majority of models yielded upper limits less
than 1°C and 4°C for exposures of first-trimester fetal tissue and
second-trimester fetal bone, respectively. The largest values obtained were
approximately 1.5°C for first-trimester fetal tissue and 7°C for
second-trimester fetal bone. Estimated maximum temperature elevations
given here are for a “fixed-path” tissue model and are for devices having
Ispta (derated) values greater than 500 mW/cm2. The temperature elevations
for fetal bone and tissue were computed based on calculation procedures
iU22 User Manual
4535 614 45861
given in Sections 4.3.2.1 through 4.3.2.6 in "Bioeffects and Safety of
Diagnostic Ultrasound" (AIUM Report, January 28, 1993).
Acoustic Output Tables
Acoustic output tables are in Acoustic Output Tables, on your user information
CD.
Acoustic Measurement Precision and Uncertainty
All table entries have been obtained at the same operating conditions that give
rise to the maximum index value in the first column of the tables. Measurement
precision and uncertainty for power, pressure, intensity, and center frequency
are listed in the following tables.
NOTE
Per Section 6.4 of the Output Display Standard, measurement precision on the
following quantities is determined by making repeated measurements and stating
the standard deviation as a percentage.
Safety
2
Acoustic Measurement Precision
pressure measured in MPa.
UD-2 definition).
intensity integral in J/cm2.
Precision (Percentage
Standard Deviation)Quantity
Pr: 5.4%Pr is the underated peak rarefactional
6.2%Wo is the ultrasonic power in mW.
<1%fcis the center frequency in MHz (NEMA
P11.3: 3.2%PII.3 is the derated spatial-peak pulse
iU22 User Manual
4535 614 45861
63
Safety
2
pressure measured in MegaPascals.
milliWatts.
UD-2 definition).
intensity integral in Joules/cm2.
Operator Safety
Acoustic Measurement Uncertainty
Measurement
Uncertainty (Percentage,
95% Confidence Value)Quantity
Pr: ±11.3%Pr is the underated peak rarefactional
±10%Wo is the ultrasonic power in
±4.7%fcis the center frequency in MHz (NEMA
PII.3: +18% to -23%PII.3 is the derated spatial-peak pulse
The following issues and situations can affect operator safety when you are using
an ultrasound system.
Repetitive Strain Injury
Repetitive ultrasound scanning has been associated with carpal tunnel syndrome
(CTS) and related musculoskeletal problems. Some investigators have looked at
a large population of sonographers with different types of equipment. An article,
with feedback from a smaller geographical area, makes the following
recommendations:
•Maintain your joints in optimum positions with a balanced posture while
scanning.
•Allow frequent breaks to give soft tissue a chance to recuperate from
awkward positions and repetitive movement.
•Avoid gripping the transducer with excessive force.
64
iU22 User Manual
4535 614 45861
Repetitive Strain References
Pike, I., et al. "Prevalence of Musculoskeletal Disorders and Related Work and
Personal Factors Among Diagnostic Medical Sonographers." Journal of DiagnosticMedical Sonographers, Vol. 13, No. 5: 219-227, September 1997.
Necas, M. "Musculoskeletal Symptomatology and Repetitive Strain Injuries in
Diagnostic Medical Sonographer." Journal of Diagnostic Medical Sonographers,
266-227, November/December 1996.
Foot Switch Warning
WARNING
Do not use the foot switch in the operating room. IEC 60601-1 specifies that
foot-operated control devices used in the operating room must be of watertight
construction. The foot switch supplied with the ultrasound system meets only
drip-proof construction requirements.
Safety
2
Philips Transducers
Use only transducers that are approved by Philips for use with your Philips
ultrasound system. See "Clinical Options and Transducers" on page 196 for a list
of the transducers that are compatible with your ultrasound system.
In the United States, the FDA 510(k) regulatory clearance for use of the product
is applicable only when Philips-manufactured transducers are connected to the
system.
Glutaraldehyde Exposure
The United States Occupational Safety and Health Administration (OSHA) has
issued a regulation covering levels of acceptable glutaraldehyde exposure in the
working environment. Philips does not sell glutaraldehyde-based disinfectants
with its products, but this type of disinfectant is recommended for the disinfection
of transducers used in TEE, intraoperative, endocavity, and biopsy procedures.
iU22 User Manual
4535 614 45861
65
Safety
2
To reduce the presence of glutaraldehyde fumes in the air, be sure to use a
covered or ventilated soaking basin. Such systems are commercially available.
The most-current information about disinfection products and Philips transducers
can be found on the Philips Transducer Care Web site:
Issues related to infection control affect the operator and the patient. Follow
the infection-control procedures established in your facility for the protection
of both the staff and the patient.
Handling Contaminated Transducers
The primary area of concern is the handling of transducers that have contacted
infected patients. Always wear gloves when you handle transducers used in TEE,
endocavity, intraoperative, and biopsy procedures that have not been previously
disinfected.
For information on cleaning and disinfecting transducers, see the "Transducer
Care" section.
Removing Blood and Infectious Material from the System
CAUTION
Do not wipe the transducer housing joint, strain relief, or cable with isopropyl
alcohol. Isopropyl alcohol can damage these parts of the transducer. This damage
is not covered by the warranty or your service contract. Also, do not use
isopropyl alcohol on TEE transducers (except for their handles).
Use a gauze pad moistened with soap and water to remove blood on the system
and the transducer connectors and cables. Then dry the equipment with a soft
cloth to prevent corrosion. You can use a 70% solution of isopropyl alcohol on
the system and only on certain parts of some transducers. Additional cleaning
agents are available for transducers. For more information, see the "Transducer
Care" section.
66
iU22 User Manual
4535 614 45861
For more information about removing blood and other infectious material from
the system, see "Disinfecting System Surfaces" on page 314.
ECG Cables and Lead Sets
For information on cleaning ECG cables and lead sets, see "Cleaning the System
and ECG Equipment" on page 311.
Disposable Drape
If you believe contamination of the ultrasound system might occur during an
exam, Philips recommends that you take universal precautions and cover the
system with a disposable drape. Consult your facility's rules regarding equipment
use in the presence of infectious disease.
CAUTION
Position the disposable drape so that it does not block the vents on the
ultrasound system, the monitors, or the peripherals.
Safety
2
Electromagnetic Compatibility
Electromagnetic compatibility (EMC) is defined as the ability of a product, a device,
or a system to function satisfactorily in the presence of the electromagnetic
phenomena that exists in the location of the product, the device, or the system
being used; and, in addition, to not introduce intolerable electromagnetic
disturbances to anything in that same environment.
Electromagnetic immunity is the ability of a product, a device, or a system to
function satisfactorily in the presence of electromagnetic interference (EMI).
Electromagnetic emissions is the ability of a product, a device, or a system to
introduce intolerable electromagnetic disturbances into the use environment.
Your system has been manufactured in compliance with existing electromagnetic
compatibility requirements. Use of this system in the presence of an
electromagnetic field can cause momentary degradation of the ultrasound image.
If this occurs often, review the environment in which the system is being used
to identify possible sources of radiated emissions. These emissions could be from
iU22 User Manual
4535 614 45861
67
Safety
2
other electrical devices used within the same room or an adjacent room, or
from portable and mobile RF communications equipment such as cellular phones
and pagers, or from the existence of radio, TV, or microwave transmission
equipment located nearby. In cases where electromagnetic interference (EMI)
is causing disturbances, it may be necessary to relocate your system.
The system complies with International Standard CISPR 11 for radiated and
conducted electromagnetic disturbances. Compliance with this standard allows
the system to be used in all establishments, including domestic establishments
and those directly connected to the public low-voltage power supply network
that supplies buildings used for domestic purposes.
WARNING
Using cables, transducers, or accessories other than those specified for use with
the system may result in increased emissions or decreased immunity of the
system.
CAUTION
Medical equipment has special precautions regarding EMC and needs to be
installed and put into service according to the EMC information provided in the
system’s accompanying documents.
NOTE
68
This section includes information on electromagnetic emissions and immunity
as it applies to the system. Ensure that the operating environment of your system
meets the conditions specified in the referenced information. Operating the
system in an environment that does not meet these conditions may degrade
system performance.
The information and warnings contained in this and other sections should be
observed when installing and using the system to ensure its EMC.
See the other electrical-safety warnings and cautions in this section.
iU22 User Manual
4535 614 45861
If the system is operated within the electromagnetic environment described in
"Electromagnetic Immunity" on page 75, the system will remain safe and will
provide the following essential performance:
•Imaging
•Doppler audio and spectral display
•Measurements
•Acoustic output
•ECG triggering
•Recording and playback on a VCR or DVD recorder
•Printing using system printers
•Patient information
•Date and time information
ECG Signal
WARNING
Operation of your system with ECG signals below 0.25 mV may cause inaccurate
results.
Safety
2
The amplitude of the electrocardiogram (ECG) signal is critical for reliable frame
triggering. Frame triggering should be used only when a clean, noise-free ECG
waveform is observed on the ECG display. The ECG signal should be at least
0.25 mV to ensure reliable triggering when the system is used in the presence
of the electromagnetic phenomena described in this section and elsewhere in
your system user information.
Electrostatic Discharge Precautions
Electrostatic discharge (ESD), commonly referred to as a static shock, is a
naturally occurring phenomenon that results in the flow of an electrical charge
from a higher charged object or person to a lower charged object or person.
ESD is most prevalent during conditions of low humidity, which can be caused
by heating or air-conditioning. During low humidity conditions, electrical charges
naturally build up on individuals and objects and can create static discharges.
iU22 User Manual
4535 614 45861
69
Safety
2
The following cautions can help to reduce ESD effect:
CAUTIONS
•Do not touch transducer connector pins or the system’s transducer
•Handle the transducer by the metal connector shell.
•Make contact with a metal surface of the system before connecting a
•The following precautions can help to reduce ESD: anti-static spray on
•
NOTE
Electrostatic discharges (ESDs) may cause the ECG heart rate display to increase
by 10% to 15% for a few seconds after the discharge. However, the ECG heart
rate display will return to normal within 4 seconds.
receptacle.
transducer to the system.
carpets; anti-static spray on linoleum; anti-static mats; or a ground wire
connection between the system and the patient table or bed.
On connectors labeled with the ESD sensitivity symbol, do not touch
the connector pins, and always observe the preceding ESD precautions
when handling or connecting transducers.
Electromagnetic Emissions
The system is intended for use in the electromagnetic environment specified in
the table. The customer or the user of the system should ensure that it is used
in such an environment.
70
iU22 User Manual
4535 614 45861
Electromagnetic Emissions: Environment Guidance
Electromagnetic
Environment GuidanceComplianceEmissions Test
Safety
2
Group 1RF emissions,
CISPR 11
The system uses only RF
energy for its internal
function. Therefore, its RF
emissions are very low and
are not likely to cause any
interference in nearby
electronic equipment.
The system is suitable for use
in all establishments, including
domestic establishments and
those directly connected to
the public low-voltage power
supply network that supplies
buildings used for domestic
purposes.
61000-3-3
Approved Cables for Electromagnetic Compliance
Cables connected to the system may affect its emissions. Use only the cable
types and lengths listed here.
WARNING
Using cables, transducers, and accessories other than those specified for use
with the system may result in increased emissions from, or decreased immunity
of, the system.
iU22 User Manual
4535 614 45861
71
Safety
2
iU22 Approved Cables
Philips Part
NumberLengthTypeCable
three-lead patient trunk cable
(for AAMI and IEC leadsets)
nondisposable (AAMI)
nondisposable (IEC)
nondisposable (AAMI)
nondisposable (IEC)
disposable (AAMI)
disposable (IEC)
–Adult and pediatric ECG
4535612272512.7 m (9 ft)
with headset
453561233291––Adult ECG leadset,
M1613A––Adult ECG leadset,
M1609A––Pediatric ECG leadset,
M1619A––Pediatric ECG leadset,
453561210001––Pediatric ECG leadset,
453561210121––Pediatric ECG leadset,
–<3 m (<9.8 ft)ShieldedAux input
72
Composite video
LAN
iU22 User Manual
4535 614 45861
–AnyShielded
coaxial
–AnyTwisted
pair
–2 m (6.5 ft)ShieldedRS-232 interface
–AnyShieldedUSB
Approved Transducers for Electromagnetic Compliance
The imaging transducers used with the system may affect its emissions. The
transducers listed in "Clinical Options and Transducers" on page 196, when used
with the system, have been tested to comply with the Group 1, Class B emissions,
as required by International Standard CISPR 11. Use only those transducers.
WARNING
Using cables, transducers, and accessories other than those specified for use
with the system may result in increased emissions from, or decreased immunity
of, the system.
Approved Accessories for Electromagnetic Compliance
Accessories used with the system may affect its emissions. The accessories listed
here, when used with the system, have been tested to comply with the Group 1,
Class B emissions as required by International Standard CISPR 11. Use only the
accessories listed here.
Safety
2
When connecting other accessories to the system, such as a remote video
monitor or computer, it is the user’s responsibility to ensure the electromagnetic
compatibility of the system. Use only CISPR 11 or CISPR 22, Class B-compliant
devices, unless otherwise noted.
WARNING
Using cables, transducers, and accessories other than those specified for use
with the system may result in increased emissions from, or decreased immunity
of, the system.
CAUTION
Use only Class-B USB storage devices with the system. Some plastic-cased
unshielded USB devices may cause RF emissions that exceed Class-B limits. See
the device’s documentation to determine whether it is Class-B compliant.
iU22 User Manual
4535 614 45861
73
Safety
2
Approved Accessories
Model NumberManufacturerAccessory
transducer
PhilipsUltrasonic imaging
MitsubishiVCR
SonyBlack and white printers
SonyColor printers
Mitsubishi
Use only the transducers
listed in "Clinical Options
and Transducers" on page
196.
HS-MD3000UA (NTSC)
HS-MD3000EA (PAL)
DVO-1000SonyDVD recorder
UP-D895MD
UP-D897MD
UP-D21MD
UP-D23MD
CP-30DW
74
color printer
report printers
iU22 User Manual
4535 614 45861
SonyLarge-format multi-image
Hewlett-PackardBlack and white LaserJet
UP-D55MD
1300
1320
Hewlett-PackardColor LaserJet printers
2550
3600
Safety
2
Model NumberManufacturerAccessory
Hewlett-PackardDeskjet printers
Hewlett-PackardOfficejet printers
Electromagnetic Immunity
The system is intended for use in the electromagnetic environment specified
here. The customer or the user of the system should ensure that it is used in
such an environment.
NOTES
•The guidelines specified here may not apply in all situations. Electromagnetic
propagation is affected by absorption and reflection from structures, objects,
and people.
•UTis the AC power voltage before application of the test level.
5650
5940
6122
K550 Officejet Pro
•At 80 MHz and 800 MHz, the separation distance for the higher frequency
range applies.
iU22 User Manual
4535 614 45861
75
Safety
2
Electromagnetic Immunity: Environment Guidance
Immunity
Test
Electrostatic
discharge
(ESD), IEC
61000-4-2
Electrical fast
transient/burst,
IEC
61000-4-4
Surge, IEC
61000-4-5
IEC 60601
Test Level
± 6 kV contact,
±8 kV air
± 2 kV for
power supply
lines, ± 8-18 kV
for
input/output
lines
± 1 kV
differential
mode, ±2 kV
common mode
Compliance
Level
Same as
IEC 60601 test
level
Same as
IEC 60601 test
level
Same as
IEC 60601 test
level
Electromagnetic
Environment Guidance
Floors should be wood,
concrete, or ceramic tile. If
floors are covered with
synthetic material, the relative
humidity should be at least
30%.
Mains power quality should be
that of a typical commercial or
hospital environment.
Mains power quality should be
that of a typical commercial or
hospital environment.
76
iU22 User Manual
4535 614 45861
Safety
2
Immunity
Test
Voltage dips,
short
interruptions,
and voltage
variations on
power supply
input lines,
IEC
61000-4-11
frequency
(50/60 Hz)
magnetic
field, IEC
61000-4-8
IEC 60601
Test Level
Drop out <40
msec
3 A/mPower
Compliance
Level
Same as
IEC 60601 test
level
Same as IEC
60691 test level
Electromagnetic
Environment Guidance
Mains power quality should be
that of a typical commercial or
hospital environment. If you
require continued operation
during power mains
interruptions, Philips
recommends that the system
be powered from an
uninterruptible power supply
or a battery.
Power frequency magnetic
fields should be at levels
characteristic of a typical
location in a typical
commercial or hospital
environment.
Conducted
RF, IEC
61000-4-6
Radiated RF,
IEC
61000-4-3
3 VRMS
150 kHz to 80
MHz
3 V/m
80 MHz to 2.5
GHz
3.0 V
3 V/m
For recommended separation
distances, see "Recommended
Separation Distance" on page
80.
For recommended separation
distances, see "Recommended
Separation Distance" on page
80.
Cables, transducers, and accessories connected to the system may affect its
immunity to the electromagnetic phenomena listed in the preceding table. Use
only approved accessories, cables, and transducers to minimize the chance of
performance degradation of the system due to those types of electromagnetic
phenomena.
iU22 User Manual
4535 614 45861
77
Safety
2
CAUTION
If the system is connected to other customer-supplied equipment, such as a local
area network (LAN) or a remote printer, Philips cannot guarantee that the
remote equipment will work correctly in the presence of electromagnetic
phenomena.
Although most remote devices comply with their applicable standards for
immunity, those device requirements may not be as stringent as those required
for medical equipment. It is the responsibility of the installer and the user of this
remote customer-supplied equipment to ensure that it functions properly in the
electromagnetic environment where the system is installed. Philips suggests that
the installer or the user of such a system consult with experts in the field of
electromagnetic compatibility and safety for guidance to ensure the safe and
effective use of the created system.
Electromagnetic Interference
Electromagnetic interference may appear in many ways on the system and
depends on the mode the equipment is operating in, the imaging control settings,
the type of transducer being used, the type of electromagnetic phenomena, and
the intensity level of the phenomena.
CAUTION
When interference is present or intermittent, use caution when continuing to
use the system.
NOTES
•Electromagnetic phenomena are not always present and may be transitory
•The following table describes a few typical interferences seen in imaging
78
iU22 User Manual
4535 614 45861
in nature. It may be extremely difficult to identify the source of the
interference.
systems. It is impossible to describe all manifestations of interference,
because it depends on many parameters of the transmitting device, such as
the type of modulation used by the signal carrier, the source type, and the
transmitted level. It is also possible for the interference to degrade the
imaging system's performance and not be visible in the image. If the
Safety
diagnostic results are suspicious, other means should be used to confirm
the diagnosis.
Typical Interference on Ultrasonic Imaging Systems
2
Imaging Mode
2D or 3D
Color
1
ESD
Change of
operating mode,
system settings, or
system reset. Brief
flashes in the
displayed or
recorded image.
Change of
operating mode,
system settings, or
system reset. Brief
flashes in the
displayed or
recorded image.
2
RF
For sector imaging
transducers, white
radial bands or
flashes in the
center lines of the
image. For linear
imaging
transducers, white
vertical bands,
sometimes more
pronounced on
the sides of the
image.
Color flashes,
radial or vertical
bands, increase in
background noise,
or changes in
image color.
Power Line
3
White dots,
dashes, or diagonal
lines near the
center of the
image.
Color flashes, dots,
dashes, or changes
in the color noise
level.
Doppler
Change of
operating mode,
system settings, or
system reset. Brief
flashes in the
displayed or
recorded image.
Horizontal lines in
the spectral display
or tones, abnormal
noise in the audio,
or both.
Vertical lines in the
spectral display,
"popping" noise in
the audio, or both.
iU22 User Manual
4535 614 45861
79
Safety
2
Imaging Mode
M-mode
1
ESD
Change of
operating mode,
system settings, or
system reset. Brief
flashes in the
2
RF
Increase in the
image background
noise or white
M-mode lines.
Power Line
White dots,
dashes, diagonal
lines, or increase in
image background
noise.
3
displayed or
recorded image.
1. Electrostatic discharge (ESD) caused by discharging of electric charge buildup
on insulated surfaces or persons.
2. Radio frequency (RF) energy from RF transmitting equipment such as portable
phones, handheld radios, wireless devices, commercial radio and TV stations,
and so on.
3. Conducted interference on power lines or connected cables caused by other
equipment, such as switching power supplies, electrical controls, and natural
phenomena such as lightning.
Recommended Separation Distance
The following table provides recommended separation distances, which are
guidelines on the distances that any RF transmitting equipment should be kept
away from the ultrasound system to reduce the risk of interference with the
system. Portable and mobile RF communications equipment should be used no
closer to any part of the system, including cables, than the recommended
separation distance calculated from the equation applicable to the frequency of
the transmitter. Field strengths from fixed RF transmitters, as determined by an
electromagnetic site survey, should be less than the compliance level in each
frequency range as noted in the table. Interference may occur in the vicinity of
equipment marked with the following symbol:.
Field strengths from fixed transmitters, such as base stations for radio
(cellular/cordless) telephones and land mobile radios, amateur radio, AM and
FM radio broadcast, and TV broadcast, cannot be predicted theoretically with
80
iU22 User Manual
4535 614 45861
NOTES
Safety
2
accuracy. To assess the electromagnetic environment due to fixed RF
transmitters, an electromagnetic site survey should be considered. If the measured
field strength in the location in which the system is used exceeds the applicable
RF compliance level in the table, the system should be observed to verify normal
operation. If abnormal performance is observed, additional measures may be
necessary, such as reorienting or relocating the system.
•For transmitters rated at a maximum output power not listed in the
following table, the recommended separation distance d in meters (m) can
be estimated using the equation applicable to the frequency of the
transmitter, where P is the maximum output power rating of the transmitter
in watts (W) according to the transmitter manufacturer.
•At 80 MHz and 800 MHz, the higher frequency range applies.
•The recommended separation distance guidelines in the following table may
not apply to all situations. Electromagnetic propagation is affected by
absorption and reflection from structures, objects, and people.
The information provided here, in conjunction with "Electromagnetic
Interference" on page 78, provides guidance on conducted and radiated
interference from portable and fixed RF transmitting equipment.
Recommended Separation Distances by Transmitter Frequency
Rated Maximum
Output Power of
150 kHz
to 80 MHz
80 to 800 MHz
800 MHz
to 2.5 GHz
Transmitter
(Watts)
0.24 m (9.5 in)0.12 m (4.7 in)0.12 m (4.7 in)0.01
0.76 m (30 in)0.38 m (15 in)0.38 m (15 in)0.1
2.4 m (7.9 ft)1.2 m (3.9 ft)1.2 m (3.9 ft)1
7.6 m (25 ft)3.8 m (12.5 ft)3.8 m (12.5 ft)10
24 m (78.7 ft)12 m (39.4 ft)12 m (39.4 ft)100
iU22 User Manual
4535 614 45861
81
Safety
2
The conducted RF test level is 3 V, and the system has a compliance level of
0.08 V. For the system, this means that the imaging system is extremely sensitive
to RF interference in the transducer passband. For example, for a 5-MHz imaging
transducer, the frequency range of interference from a 3-V/m field may be from
2 to 10 MHz and manifest itself as described in "Electromagnetic Interference"
on page 78.
The 0.08-V level is where the interference becomes acceptable to some clinical
specialists.
Sensitivity to interference is dependent on operating mode and imaging control
settings. The order of increasing sensitivity to interference as a function of
operating mode is 2D mode, 3D mode, M-mode, Color mode, PW Doppler
mode, and CW Doppler mode. The system is more sensitive to interference in
the CW Doppler or PW Doppler operating modes, but the probability of
interference is lower than in 2D mode or Color mode, because the susceptible
frequency range is lower. Therefore, you are more likely to see interference in
2D or Color modes.
As an example, if a portable transmitter has maximum radiated power of 1 W
and an operating frequency of 156 MHz, it should only be operated at distances
greater than 1.2 m (3.9 ft) from the system. Likewise, a 0.01-W Bluetooth wireless
LAN device operating at 2.4 GHz should be placed no closer than 0.24 m (9.5 in)
from any part of the system.
Avoiding Electromagnetic Interference
A medical device can either generate or receive electromagnetic interference.
The EMC standards describe tests for both emitted and received interference.
Emission tests deal with interference generated by the device being tested. Philips
ultrasound systems do not generate interference based on the tests described
in the referenced standards.
An ultrasound system is designed to receive signals at radio frequencies and is
therefore susceptible to interference generated by RF energy sources. Examples
of other sources of interference are medical devices, information technology
products, and radio and television transmission towers. Tracing the source of
82
iU22 User Manual
4535 614 45861
Safety
2
radiated interference can be a difficult task. Customers should consider the
following in an attempt to locate the source:
•Is the interference intermittent or constant?
•Does the interference show up only with one transducer or with several
transducers?
•Do two different transducers operating at the same frequency have the
same problem?
•Is the interference present if the system is moved to a different location in
the facility?
•Can the EMC coupling path be attenuated? For example, placement of a
transducer or printer close to an ECG cable can increase electromagnetic
interference. Moving the cable or other medical equipment away from the
location of the transducer or printer can result in reduced electromagnetic
interference.
The answers to these questions will help determine if the problem resides with
the system or the scanning environment. After you answer the questions, contact
your Philips service representative.
Use Restrictions Due to Interference
The physician needs to determine if an artifact caused by radiated interference
will have a negative impact on image quality and the subsequent diagnosis.
iU22 User Manual
4535 614 45861
83
Safety
2
84
iU22 User Manual
4535 614 45861
3System Overview
Use this section to acquaint yourself with the ultrasound system and its
components.
System Capabilities
The iU22 Ultrasound System is a high-resolution system intended for general
imaging and shared services. The cart is ergonomically designed to be both
highly mobile and adjustable for a range of users and operating conditions. You
can use it for 2D, 3D, 4D, Live 3D, Volumetric, xPlane, M-mode, Doppler,
Color, and Color Power Angio (CPA) imaging. You can also perform Duplex,
Triplex, and Live xPlane imaging. Stress echocardiography is standard on the
system, and QLAB Advanced Quantification Software plug-ins are available as
options. The system supports a wide range of transducers. The system provides
measurement tools, calculations options, and DICOM network capabilities.
Measurements
The system provides tools and controls for measuring distance, area, and
volume. In calculations, the following application-specific tools are available:
•2D Depth
•3D Volume
•Distance
•Ellipse
•Convert to Ellipse
•Continuous Trace
•Trace by Points
•Curved Distance
•Volume
iU22 User Manual
4535 614 45861
85
System Overview
3
•Stacked Contours
•Hip Tools
•Volume Flow
•% Reduction
•Heart Rate
•Time/Slope
After you perform measurements, the system makes the pertinent calculations
and organizes the measurements, calculations, and patient information into a
patient report. For information, see the Help. To display the Help, press Help
on the keyboard.
Transducer Types
Available transducers include curved, sector, linear, compact linear,
transesophageal, endocavity, intraoperative, CW, 3D, and for Live xPlane and
3D imaging, xMATRIX transducers.Applications for specific transducers are listed
in "Clinical Options and Transducers" on page 196.
Image Capture and Review
You can capture and review single images and Philips Cineloop sequences. Images
and Cineloop sequences can be stored on digital versatile discs (DVD RW) or
sent over a network to an archive server or a printer.
Stress Echo capabilities also make use of the ability to capture and review image
loops. Stress Echo protocols of up to eight stages are used to assess cardiac wall
motion at various heart rates.
Peripheral devices are available for recording images and exams. You can add a
VCR to the system and connect a black-and-white page printer or a color page
printer. You can also connect a report printer.
Patient Data Protection
The data security feature, if enabled on your system, limits access to previously
stored patient data and images. To gain access to such data, you must first log
86
iU22 User Manual
4535 614 45861
on to the system using a password. When you are finished using the system, you
can log off manually, or you can simply shut down the system, which logs you
off automatically. The system stores a record of each user logon.
This data protection feature can be used to help meet the requirements of the
U.S. Health Insurance Portability and Accountability Act (HIPAA), which became
effective April 2003.
For more information on protecting patient data, see "System Security" on page
155.
System Options
In addition to the standard features available in the system, other features are
available as purchasable options. The types of options available include clinical
options, QLAB Advanced Quantification Software, protocols, imaging capabilities,
and connectivity capabilities. A foot switch is available as an option.
Imaging Options
System Overview
3
Once purchased, the imaging options listed here are available as supported by
the current transducer and application:
•2D iSCAN Intelligent Optimization
•3D freehand
•3D/4D (mechanical transducers)
•Live 3D and xPlane (xMATRIX transducers)
•Fetal Spatio-temporal Image Correlation (STIC)
•iSTIC
•Doppler iSCAN Intelligent Optimization
•Elevation Compounding
•Panoramic Imaging
•Physio
•SonoCT Real-time Compound Imaging
•Voice control
iU22 User Manual
4535 614 45861
87
System Overview
3
•XRES Image Processing
•Volumetric Imaging
•Elastography
NOTE
The Elastography feature is only available in selected regions. For information
specific to your region, contact your local Philips representative.
Voice Control Option
The voice control option allows you to operate the system using voice commands
transmitted through a wireless headset. You can also use voice control to add
text annotation to images. The voice control option can recognize commands
in English, French, Italian, German, and Spanish.
Connectivity Options
The following features are standard:
88
•Image and waveform export to removable media
•Printing to DICOM printers
•Printing to local printers
•Printing report pages
In addition to those standard features, the Basic Connectivity purchasable option
includes the following features:
•Image and waveform export to network storage servers
•DICOM worklist
•DICOM performed procedure step (PPS)
•DICOM storage commit (SC)
•DICOM Structured Reporting option
iU22 User Manual
4535 614 45861
Clinical/Analysis Options
Clinical options are available on the system as separate purchasable options. The
following clinical packages and their applications (for example, small parts
superficial) are associated with specific transducers:
•Abdomen
•Adult Echo
•Contrast
•GYN
•Intervention
•Musculoskeletal
•OB
•Pediatric
•Small Parts
•Urology
•Vascular
System Overview
3
Calculations Package Options
•Abdominal
•Adult Echo
•Fetal Echo
•General
•GYN
•OB
•Small Parts
•Vascular
iU22 User Manual
4535 614 45861
89
System Overview
3
QLAB Advanced Quantication Software Options
The following QLAB Advanced Quantification Software plug-ins are available as
separate options:
•IMT (Intima-Media Thickness) measurement and quantification
•Cardiac 2DQ basic measurement and quantification
•Cardiac 3DQ basic measurement and quantification
•GI 3DQ basic measurement and quantification
•ROI (Region of Interest) quantification tools
•SQ (Strain Quantification) for Tissue Doppler Imaging
•MVI (MicroVascular Imaging) for assessing intensity changes over time
NOTES
•Instructions for using the QLAB plug-ins are included in QLAB Help, which
is available by pressing the Help key while QLAB plug-ins are active.
•To ensure viewing compatibility of your QLAB Advanced Quantification
files on a PC, ensure the QLAB software on your PC is the same version
as that on your system.
•When acquiring images, do not have both black-and-white and color
suppression enabled.
Stress Echocardiography
Stress Echocardiography (Stress Echo) is a protocol-driven study that allows a
cardiologist to assess cardiac wall motion at various heart rates by acquiring
views of the heart at different stages of the study. Stress Echo includes these
Philips protocols:
•Exercise 2-Stage
•Exercise 3-Stage
•Pharmacological 4-Stage
•Wall Motion and Contrast
•Quantitative 4-Stage
90
iU22 User Manual
4535 614 45861
You can create custom presets based on those protocols.
Data Security
A data security feature is available to help maintain the confidentiality of archived
patient files. With this option, access to patient exam files is restricted to
authorized personnel through user ID and password protection. For more
information, see "Patient Data Protection" on page 86.
Technical Administration Option
The system includes many diagnostic capabilities as standard features, such as
error handling and remote access for diagnosing the system. The technical
administration option adds the following capabilities:
•Advanced tests and other diagnostic tools
•Automatic monitoring and logging of system operating parameters and
usage; warnings when operating limits are exceeded
•Enhanced capabilities for self diagnosis
•Enhanced error handling and notification
•Preventive maintenance logging and notification
•Reporting of system and component configuration
•Secure technical administration interface
System Overview
3
PercuNav Image Fusion and Navigation Device
You can use the PercuNav Image Fusion and Navigation Device to guide needles
or probes using pre-procedure or intra-procedure images. By tracking the tip
of flexible or rigid instruments using tiny sensors embedded in the tips of the
instruments, the system provides real-time three-dimensional visualization and
navigation during diagnosis and interventions.
Features include the following:
•Flexible instruments
•Multiple applications
•Multiple modalities
iU22 User Manual
4535 614 45861
91
System Overview
3
Instructions for using PercuNav are in the PercuNav User Manual.
NOTE
PercuNav is a purchasable licensed option. Its user interface is available only
when the PercuNav license is enabled.
System Components
The system is housed in an ergonomic cart. The cart is adjustable to
accommodate a wide range of operator heights and operating positions.
Adjustable components can be locked in place so the cart can be safely moved.
The major components include the monitor, control module, On/Off switch,
DVD RW drive, peripheral bay, transducer receptacles, ECG/physio receptacles,
foot pedals, foot switch receptacle, and rear-panel power switch and audio/video
receptacles.
92
iU22 User Manual
4535 614 45861
System Components
System Overview
3
Monitor1
On/Off switch2
Transducer receptacles3
iU22 User Manual
4535 614 45861
93
System Overview
3
Control module4
ECG/physio receptacles5
Foot switch receptacle6
Brake/steering lock foot pedal7
DVD RW drive8
Peripheral bay9
Rear panel (audio, video, and network receptacles)10
Power switch11
Video Monitor
The system video monitor consists of a 43-cm (17-in) or 51-cm (20-in) flat-panel
display on an articulated mounting arm. The monitor is adjustable to
accommodate different operating positions and operator heights. The monitor
can also be locked in position for moving the system (see "Moving the System"
on page 116).
Control Module
The control module includes three main components: the control panel, the
touch screen, and the keyboard. For more information on the control module,
refer to "System Controls" on page 132.
The control panel contains the main imaging controls. These controls include
buttons, knobs, TGC slide controls, and a trackball. The control module also
allows you to select transducers, enter patient data, review and annotate images,
perform measurements and calculations, and change setups.
The touch screen, located above the control panel, display controls used to
select applications and imaging modes, as well as controls that are specific to the
current operating mode. Touch screen controls include buttons and knob displays.
94
iU22 User Manual
4535 614 45861
Control Module Components
System Overview
3
Control panel1
Touch screen2
Trackball3
TCG slide controls4
You can adjust the position of the control module vertically and side-to-side.
You can also swivel the control module.
Beneath the control panel is a retractable keyboard. The keyboard is used to
enter patient data, comments, and text annotation on images. A light above the
keyboard is switched on when the keyboard is pulled out.
iU22 User Manual
4535 614 45861
95
System Overview
3
Voice Control Headset
The optional voice control feature allows you to operate the system when the
control module is out of reach or you need both hands for scanning. You can
also use voice control to add text annotation to images. Voice control uses a
wireless headset to send your voice commands to the system.
Voice Annotation Microphone
The voice annotation microphone allows you to record comments on a videotape
or DVD. The microphone is in the monitor housing.
On/Off (Power) Control
The On/Off switch is to the left of the DVD RW drive on the front of the
system, above the control module. When the system is off, pushing this control
brings the system into a fully operational state. Pushing this control again turns
off the system.
96
iU22 User Manual
4535 614 45861
Data Storage
On/Off Control
System Overview
3
You can store exam data and images onto removable media. Removable media
includes USB storage devices and the DVD RW drive, which is located above
the control panel. The system hard drive is located inside the system.
iU22 User Manual
4535 614 45861
97
System Overview
3
DVD RW Drive
98
iU22 User Manual
4535 614 45861
USB Port Location
System Overview
3
Peripherals
The peripheral bays at the back of the system provide space for up to three
peripheral devices. Those devices can be any combination of the following devices:
a black-and-white printer, a color printer, and a DVR or VCR. The third
peripheral bay replaces the TEE transducer tray, so you can have either a third
peripheral device or a TEE transducer tray, but not both. The devices can be
USB port1
iU22 User Manual
4535 614 45861
99
3
NOTE
System Overview
installed in the peripheral bay for access from either the right or left side of the
system.
If your system configuration includes the PercuNav Image Fusion and Navigation
Device option, then the only other peripheral device that you can include on
the back of the system is the black-and-white printer, which must be installed
in the third peripheral bay.
Peripheral Bays
100
Black-and-white printer1
Printer2
DVR or VCR3
iU22 User Manual
4535 614 45861
Loading...
+ hidden pages
You need points to download manuals.
1 point = 1 manual.
You can buy points or you can get point for every manual you upload.